The global clinical trial supplies market consists of various products and services that are used in clinical trials. This market is driven by several factors such as globalization of clinical trial activities, increasing R&D investments and government support, rising incidences of various diseases, and increasing expansion activities by CROs.
Increasing patent expiry, the development of generic drugs, and high potential growth in emerging markets are all factors that have opened an array of opportunities for the clinical trial supplies market. However, factors such as longer approval times for clinical trials are hampering the growth of the global clinical trial supplies market.
The clinical trial supplies market is expected to reach USD 1,274.3 million by 2020 from USD 904.3 million in 2015, at a CAGR of 7.1%. This market is segmented based on products and services, phases, therapeutic areas, and regions.
Target Audience for this Report:
Clinical trial supplies CROs
Healthcare Institutions (Hospitals and Clinics)
Clinical Trial Supplies Service Providers
Research Institutions
Research and Consulting Firms
Environment, Health, and Safety Organizations
Clinical Trial Supplies Market in Therapeutic Area:
Oncology
Cns and Mental Disorders
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
Blood Disorders
Dermatology
To know about the assumptions considered for the study, Get FREE Sample Pages: http://bit.ly/2tOkOO3

The global clinical trial supplies market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).
The major players in this market include Alamc Group LTD (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), Biocair (U.K.), and Thermo Fisher Scientific, Inc. (U.S.).
Download PDF Brochure: http://bit.ly/2txLhEe